Delivery Order SPE2DR25D3005-SPE2DR26FP9AG
- Not listed
- The Defense Logistics Agency awarded a $11,536.50 delivery order to AmerisourceBergen Drug Corp on January 23, 2026, for the supply of Gel-One 30 mg/3 mL syringes. This is a firm fixed-price contract with an ultimate completion date of February 13, 2026, and represents a non-competitive set-aside award. The product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. As a child entity of parent company Cencora, Inc.,...
- On January 14, 2026, the Defense Logistics Agency awarded a delivery order valued at $9,229.20 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes (3 mL). This firm fixed-price delivery order is not set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of February 5, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,538.20 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on January 27, 2026, with an ultimate completion date of February 18, 2026. This firm fixed-price delivery order, which was not set-aside, represents a continuation of pharmaceutical supply services under the company's broader contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $9,122.50 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on a firm fixed-price basis. The contract, awarded on November 5, 2025, represents a non-competitive delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. Performance is scheduled to be completed by November 28, 2025, with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,073.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes (3 mL) on December 30, 2025, with an ultimate completion date of January 22, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $13,459.25 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on December 1, 2025, with completion scheduled for December 22, 2025. This firm fixed-price, non-set-aside delivery order will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected through competitive procurement...
- The Defense Logistics Agency awarded a delivery order valued at $19,227.50 to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Gel-One 30 mg/3 ml syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 22, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $7,298.00 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This competitively awarded, firm fixed-price contract is classified as a non-set-aside delivery order with performance to be completed by October 9, 2025, at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $7,691.00 by the Defense Logistics Agency on January 20, 2026, for the supply of Gel-One 30 mg/3 mL syringes. The contract is a firm fixed-price, non-set-aside award with performance scheduled to be completed by February 10, 2026, with the place of performance located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Gel-One 30 mg/3 mL syringes valued at $5,768.25 with a firm fixed price structure. This is a non-set-aside competitive award with performance scheduled for completion by December 5, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP9AGDelivery Order
The Defense Logistics Agency awarded a $9,229.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Gel-One 30 mg/3 ml syringes. This is a non-set-aside contract with performance scheduled to conclude by February 20, 2026, with the product to be delivered to the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under a larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The parent indefinite delivery contract serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs worldwide. The delivery order structure demonstrates the company's role as a critical vendor in the federal medical supply chain, consistently fulfilling competitively awarded contracts for pharmaceutical and medical commodity procurement across defense and healthcare agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 1/28/26 |